from the Euro presentation:
p30
"current cash = $188mil
future cash flow:
Abbott/J&J (US$55-60mil) to Q1 2011."
plus other upfronts/milestones/royalties.
I guess they could afford a dividend,
but it's just my opinion they really want to get some of their own antibodies to market for some security.
I don't hold for exactly that reason, am watching it very closely. I used to hold in EGX days but sold after the merger. It must be frustrating for PTD holders.
- Forums
- ASX - By Stock
- AAH
- frustrated
AAH
arana therapeutics limited
frustrated, page-9
-
- There are more pages in this discussion • 2 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add AAH (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
I88
INFINI RESOURCES LIMITED
Charles Armstrong, CEO & Managing Director
Charles Armstrong
CEO & Managing Director
SPONSORED BY The Market Online